March 2010 - Volume 39 - Issue 2
pp: 119-282


CO2 Abdominal Insufflation Decreases Local and Systemic Inflammatory Response in Experimental Acute Pancreatitis

Machado, Marcel Cerqueira Cesar; Coelho, Ana Maria Mendonça; Martins, Joilson O.; More

Pancreas. 39(2):175-181, March 2010.

Mutational Analysis of the Gene Encoding the Zymogen Granule Membrane Glycoprotein 2 (GP2) in Patients With Chronic Pancreatitis

Witt, Heiko; Rosendahl, Jonas; te Morsche, René H.M.; More

Pancreas. 39(2):188-192, March 2010.



Abstracts Presented at the 2nd Annual Meeting of the North American NeuroEndocrine Tumor Society, October 2-3, 2009, Charlotte, North Carolina


RUNXT1 and Palladin Outperform Pathologic Criteria of Malignancy in Predicting Liver Metastases in Primary Pancreatic Endocrine Carcinomas

Nasir, Aejaz; Henderson-Jackson, Evita B.; Helm, James; More

Pancreas. 39(2):277, March 2010.

Discovery and Validation of a Novel Set of Putative Progression Markers in Well-Differentiated Primary Pancreatic Endocrine Carcinomas

Nasir, Aejaz; McCarthy, SM; Nasir, Nelly A.; More

Pancreas. 39(2):277-278, March 2010.

Development of a Highly Sensitive and Specific Carboxy-Terminal Human Pancreastatin Assay to Monitor Neuroendocrine Tumor Behavior

O'Dorisio, Thomas M.; Krutzik, Siegfried R.; Woltering, Eugene A.; More

Pancreas. 39(2):279, March 2010.

Initial Impact of a Systematic Multidisciplinary Approach on the Management of Patients With Gastroenteropancreatic Neuroendocrine Tumor

Tamagno, Gianluca; McGowan, Lisa; King, Romaine; More

Pancreas. 39(2):281, March 2010.

A Large-scale SNP Evaluation Reveals an Association of a TSC2 SNP with Sporadic Neuroendocrine Tumor Risk

Ter-Minassian, Monica; Wang, Zhaoxi; Asomaning, Kofi; More

Pancreas. 39(2):281, March 2010.

Daily Oral Everolimus Activity in Patients with Metastatic Pancreatic Neuroendocrine Tumors after Failure of Cytotoxic Chemotherapy: A Phase II Trial

Yao, James C.; Lombard-Bohas, Catherine; Baudin, Eric; More

Pancreas. 39(2):282, March 2010.

1 2 3 4 5